Drugs

Arndt Vogel: Access to new medicines in Canada, Europe, and the United States

Arndt Vogel/X

Apr 16, 2024, 07:45

Arndt Vogel: Access to new medicines in Canada, Europe, and the United States

Arndt Vogel shared on X/Twitter:

“Access to new medicines in Canada, Europe, and the United States: Study finds less availability and longer waits for Canadian patients.
Canada lags far behind US and EU.
Clear demands to improve access to innovative therapies.

CADTH, Health Canada and PHAC: read carefully!”

Source: Arndt Vogel/X

Arndt Vogel is a managing senior consultant and professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. He is the Head of the GI-Cancer Center and of the Center for Personalized Medicine at Medical School Hannover and chairs the Hepatobiliary Cancer Study Group of the AIO, a collaborative group in clinical oncology in Germany. His scientific focus is translational and clinical research in gastrointestinal cancer.

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”